By Marc Darrow, MD, JD
A 37-year-old reader describes severe jaw pain and a temporomandibular joint that is “nearly bone on bone.” Physical therapy, a night guard, and surgery have been discussed. The reader wants to know whether PRP or a stem-cell-related treatment might help, what information is needed before a decision, and whether traveling across the country makes sense.
Regenerative injections are worth discussing as possible symptom treatments, but none should be presented as a reliable way to rebuild a nearly bone-on-bone TMJ. The first task is to establish the diagnosis and the source of the pain. Then we can consider whether an injection has a reasonable target and how its evidence compares with other options.
What does “nearly bone on bone” mean in the jaw?
The TMJ contains joint surfaces, a fibrocartilaginous disc, a capsule, and surrounding muscles. The condyle is the rounded part of the lower jawbone within the joint. Pain may arise from the joint, the chewing muscles, a disc problem, or several structures together.
The phrase “bone on bone” needs clarification. Does the report describe loss of joint space, erosion or flattening of the condyle, disc displacement, or another finding? Are older images available to show whether the appearance is stable or changing?
CT and cone-beam CT are useful for evaluating bone. MRI addresses questions about the disc and other soft-tissue findings, including joint fluid. They answer different questions. A specialist should select imaging based on the examination and the suspected problem rather than ordering every scan for every patient. (1)
At 37, substantial joint change deserves a clear explanation. Depending on the history, the assessment may need to consider prior trauma, inflammatory arthritis, disc pathology, or a condylar resorption process. Young age does not establish that an injection will regrow cartilage, and severe imaging changes do not identify every contributor to pain.
Why physical therapy and a night guard may still be part of care
Physical therapy and a carefully selected oral appliance may address muscle loading, movement, or habits that aggravate symptoms. They should not be described as treatments that replace lost cartilage. Persistent pain is a reason to reassess the diagnosis and treatment plan, not proof that every conservative option is pointless.
NIDCR recommends starting with simpler approaches and carefully weighing irreversible interventions. A night guard should not be designed to permanently change the bite, and worsening symptoms warrant review. (2)
Jaw and neck symptoms can coexist. A neck examination may be relevant when symptoms suggest a cervical contribution, but neck pain does not establish that cervical instability caused the jaw degeneration.
What should the examination establish?
I would want to distinguish joint pain from muscle pain and determine what reproduces the familiar symptoms. Relevant questions include:
- Is one side painful, or both?
- How far can the mouth open, and is opening limited by pain, locking, or a mechanical block?
- Is there clicking, grinding, recurrent dislocation, or a changing bite?
- Does chewing, talking, yawning, or waking in the morning provoke symptoms?
- Was there an injury, prior dental or jaw treatment, or another joint condition?
- Which treatments helped, for how long, and which made symptoms worse?
Dental causes, muscle pain, headaches, and neuropathic facial pain may need separate evaluation. An injection into a joint is less likely to address symptoms arising mainly from another structure.
Can PRP help TMJ arthritis?
PRP is prepared from the patient’s blood and contains concentrated platelets. It is not a stem-cell treatment. The clinical question is whether a specified preparation improves pain or function for a defined TMJ disorder.
Earlier clinical research remains relevant
A 2015 randomized study enrolled 50 people with TMJ osteoarthritis, ages 31–49. Three PRP injections were compared with three hyaluronic acid injections. Hyaluronic acid performed better at earlier assessments, while PRP performed better at later follow-up. This age range is relevant to the reader, but the study did not establish that a 37-year-old with end-stage structural loss will regrow cartilage. (3)
2025 research: possible benefit after joint lavage
A 2025 meta-analysis of six randomized studies involving 199 patients found that adding PRP after joint puncture improved pain and some mouth-opening outcomes compared with controls. Longer-term findings were less certain, and the studies varied. (4)
In a separate 2025 randomized trial, 46 patients with joint-related TMJ disorders received arthrocentesis followed by either hyaluronic acid plus PRP or hyaluronic acid alone. The combination produced better pain and mouth-opening outcomes at several follow-ups, with fewer reinterventions by one year. The study was small, involved a mixed joint-disorder population, and tested a combined procedure. It did not isolate an office PRP injection or demonstrate cartilage restoration. (5)
2026 research: PRP compared with conditioned serum
A trial first published online in September 2026 randomized 75 people with TMJ osteoarthritis to arthrocentesis alone, arthrocentesis plus PRP, or arthrocentesis plus autologous conditioned serum. Both biological additions improved clinical outcomes compared with lavage alone through six months, without consistent superiority of one over the other. (6)
Conditioned serum is a blood-derived preparation distinct from PRP. A study comparing them does not establish that either reliably rebuilds a damaged jaw joint.
Why does arthrocentesis matter when reading the research?
Arthrocentesis is washing or irrigating the joint through needles. It is more than simply giving an injection. If every study participant receives lavage, improvements cannot automatically be attributed entirely to the material added afterward.
A review published online in 2025 and in print in 2026 examined PRP without arthrocentesis. Across six randomized trials, it found potentially useful symptom effects, but certainty ranged from moderate to low and no trial assessed quality of life. (7)
Before selecting treatment, clarify whether the proposed procedure is an injection alone, injection after lavage, or an intervention during arthroscopy. Findings for one approach should not be used to promise the same result with another.
What do marrow-based TMJ studies show?
A small randomized trial compared marrow nucleated-cell concentrate with hyaluronic acid after lavage in 30 patients. Some pain, chewing, and opening outcomes favored marrow at later follow-up, but MRI showed no evidence of cartilage regeneration. (8)
Another study, published online in 2023 and in print in 2024, compared BMAC with hyaluronic acid after arthrocentesis in 24 patients. Its authors reported favorable longer-term findings with BMAC. The sample was small and did not establish predictable restoration of a nearly bone-on-bone joint. (9)
These are reasons for further research and a careful treatment discussion. They do not establish that marrow treatment is superior to PRP for this reader or that it will prevent surgery.
How do other injections differ?
Corticosteroid and hyaluronic acid
Corticosteroids aim to reduce inflammation; hyaluronic acid is used for its joint-fluid-related properties. Neither should be sold as a guaranteed cartilage-regrowing treatment. In a study of rheumatoid arthritis involving the TMJ, steroid injections provided temporary symptom and opening improvement. Those findings concern an inflammatory disease and cannot automatically be applied to primary degenerative arthritis. (10)
Botulinum toxin
Botulinum toxin is generally directed at muscles and should be evaluated as a muscle-focused treatment. It is not equivalent to an intra-articular injection and has not established restoration of lost joint cartilage. Muscle symptoms and severe joint degeneration need to be assessed separately.
Dextrose prolotherapy
A 2024 randomized trial compared ultrasound-guided and nonguided dextrose injections in 22 patients with painful clicking and disc displacement with reduction. Both groups improved, with no significant difference in pain between approaches. There was no placebo group. This concerns internal derangement, not a demonstration of cartilage regrowth in advanced TMJ osteoarthritis. (11)
Wharton’s jelly, cord products, and exosomes
These are distinct investigational categories. A tissue allograft is not automatically a living stem-cell preparation, and a cultured-cell study does not establish the effectiveness of a non-expanded tissue product. FDA states that the regenerative products addressed in its consumer guidance have not been approved for orthopedic conditions and require appropriate investigational oversight. (12)
Is surgery the only remaining option?
Not every surgical discussion concerns total joint replacement. Arthrocentesis, arthroscopy, and open reconstruction are different procedures with different indications. A specialist should explain what the proposed procedure is intended to change and why it is appropriate for the particular joint problem.
Severe pain or progressive structural disease deserves a timely orofacial pain or oral and maxillofacial specialist assessment. Seeking a regenerative opinion can be part of that process, but should not require abandoning appropriate evaluation of a changing bite, condylar loss, or another mechanical problem.
What would count as a worthwhile result?
Meaningful goals might include eating a broader range of foods, opening more comfortably, sleeping better, or reducing pain during conversation. Those gains matter even when imaging does not show new cartilage.
For this 37-year-old, I would separate the hope of symptom relief from the claim of cartilage regeneration. The next decision should follow a clear diagnosis, a procedure-specific evidence discussion, and an agreed plan for assessing progress.
Related reading
- TMJ treatment options and treatment selection
- TMJ and neck pain
- Botulinum toxin and muscle-related TMJ pain
- Understanding PRP preparations
References
1 Mallya SM, Ahmad M, Cohen JR, Kaspo G, Ramesh A. Recommendations for Imaging of the Temporomandibular Joint. Position Statement from the American Academy of Oral and Maxillofacial Radiology and the American Academy of Orofacial Pain. J Oral Facial Pain Headache. 2023;37(1):7-15. doi:10.11607/ofph.3268.
2 National Institute of Dental and Craniofacial Research. TMD (Temporomandibular Disorders). National Institutes of Health. Accessed November 19, 2026.
3 Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-Rich Plasma Injection as an Effective Treatment for Temporomandibular Joint Osteoarthritis. J Oral Maxillofac Surg. 2015;73(9):1706-1713. doi:10.1016/j.joms.2015.03.045.
4 Xu F, Zhang J, Wu I, Xu Y, Yu T, Kang J, Wu F. Does intra-articular injection of PRP help patients with temporomandibular joint osteoarthritis after joint puncture? a systematic review and meta-analysis of randomized controlled trials. BMC Oral Health. 2025;25(1):475. doi:10.1186/s12903-025-05826-5.
5 Ângelo DF, Cardoso HJ, Sanz D, Maffia F, Sarkis M, Mota B, Salvado F. Double-Puncture Arthrocentesis in Arthrogenous TMJ Disorders: Bioviscosupplementation vs. Viscosupplementation a Randomized Controlled Trial. J Clin Med. 2025;14(11):3750. doi:10.3390/jcm14113750.
6 Uysal RFG, Uysal I. Comparison of Autologous Conditioned Serum and Platelet-Rich Plasma Following Arthrocentesis in Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial. J Oral Rehabil. 2026;53(12):2414-2423. doi:10.1111/joor.70314. First published online September 24, 2026.
7 Wielandt V, Verdugo-Paiva F, Oyarzo JF, Iglesias-Ibernia Z, Saro-Piaya E, Vázquez-Delgado E. Exploring the efficacy and safety of platelet-rich plasma without arthrocentesis in temporomandibular joint degenerative disease treatment: A systematic review and meta-analysis. Cranio. 2026;44(2):342-363. doi:10.1080/08869634.2025.2521563.
8 De Riu G, Vaira LA, Carta E, Meloni SM, Sembronio S, Robiony M. Bone marrow nucleated cell concentrate autograft in temporomandibular joint degenerative disorders: 1-year results of a randomized clinical trial. J Craniomaxillofac Surg. 2019;47(11):1728-1738. doi:10.1016/j.jcms.2018.11.025.
9 Fayed HM, Khairy MA, Eldahshan D, Sabry D, Ahmed WA. Bone marrow aspirate concentrate – A novel approach to alter the course of temporomandibular joint osteoarthritis (a clinical study). J Stomatol Oral Maxillofac Surg. 2024;125(1):101644. doi:10.1016/j.jormas.2023.101644.
10 Kroese JM, Kopp S, Lobbezoo F, Alstergren P. Corticosteroid injections in the temporomandibular joint temporarily alleviate pain and improve function in rheumatoid arthritis. Clin Rheumatol. 2021;40(12):4853-4860. doi:10.1007/s10067-021-05860-y.
11 Alhaj Kheder MB, Kandil NM, El-Ghareeb T, Abdel Aziz OM, Zeitoun R. Ultrasound-Guided Vs Non-Guided Prolotherapy for Internal Derangement of Temporomandibular Joint. A Randomized Clinical Trial. J Ultrasound Med. 2024;43(8):1401-1412. doi:10.1002/jum.16462.
12 U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies. June 3, 2021. Accessed November 19, 2026.





